Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement
Introduction
Injection drug users (IDU) suffer high morbidity and mortality due to preventable conditions, including human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), sexually transmitted infections (STIs), tuberculosis (TB), and accidental overdose (Kral et al., 2003, Kral et al., 2004, Kuo et al., 2004, Friedman et al., 2003, Murrill et al., 2002, Seal et al., 2001, Davidson et al., 2003, Coffin et al., 2003; CDCP, 2003b, CDCP, 2004; Perlman et al., 1995). In the United States (US), the Centers for Disease Control and Prevention (CDC) recommends that IDUs receive comprehensive preventive services to address these multiple sources of risk, including screening for infectious diseases, vaccinations, risk reduction counseling, drug treatment/counseling, and access to sterile syringes (Academy for Educational Development, 2000). Yet, these preventive services cannot result in improvements in health if at-risk IDUs do not receive them.
Recent studies have documented significant deficits in the quality of care provided by the US health care system (Schuster et al., 1998), with Americans receiving on average only about 50% of recommended preventive services (McGlynn et al., 2003). While the quality of preventive care received by vulnerable populations such as IDUs has not been systematically evaluated, there is reason to believe that IDUs may fail to receive recommended preventive care. For example, IDUs have poor access to traditional sources of preventive care, including primary care providers (Chitwood et al., 1999, Chitwood et al., 2001, Chitwood et al., 2002, French et al., 2000, Riley et al., 2002c) and drug treatment programs (Wenzel et al., 2001, Wu et al., 2003). And although providers have adopted a variety of low threshold community-based approaches to delivering preventive services to marginalized IDUs, including providing preventive services via street outreach, and at homeless shelters, drop-in centers, and syringe exchange programs (SEPs), few studies have determined if IDUs using these low threshold services are receiving recommended preventive care. As a result, studies to identify unmet need for preventive care among IDUs, as well as successful strategies for delivering preventive services to IDUs, are needed.
Of low threshold providers, SEPs, which distribute sterile syringes to IDUs in order to reduce HIV transmission via syringe sharing, are uniquely positioned to deliver preventive services to IDUs due to their ability to successfully attract highly marginalized IDUs with frequent high-risk behaviors (Hahn et al., 1997, Hagan et al., 2000, Miller et al., 2002) and therefore high need for preventive care. While multiple studies have established the effectiveness of SEPs in preventing transmission of HIV via syringe sharing (Gibson et al., 2001), less is known about the role of SEPs in providing preventive services to IDUs.
Previous studies evaluating preventive services available at selected SEPs have found delivery of preventive services to IDUs at SEPs to be feasible and effective, including vaccinations (Stancliff et al., 2000, Des Jarlais et al., 2001), screening for HIV and STIs (Liebman et al., 2002), and screening for tuberculosis (Perlman et al., 1997, Perlman et al., 2001, Riley et al., 2002b). But other studies suggest that these findings may not be generalizable to SEPs and IDUs in other communities. For example, a national survey of US SEPs found that availability of preventive services at SEPs varies, with on-site HIV testing and counseling available at 64% of SEPs, but HCV testing available at only 24% of SEPs, HBV vaccinations at only 16%, and STI testing at only 13% (Centers for Disease Control and Prevention, 2001). While SEP preventive services may be potentially effective, IDUs may still fail to receive needed services if services are not available from the SEP and are not received from other sources, suggesting that additional studies examining use of preventive services among IDUs from multiple SEPs, and including services from SEPs and non-SEP sources, are needed. In addition, a study comparing use of a variety of preventive services among SEP clients and methadone maintenance patients in Rhode Island found that although the majority of IDUs in both groups had received screening for HIV and TB, many SEP clients had not received testing for HCV, HBV, and STIs or vaccination against HBV (McGarry et al., 2002). Previous studies have focused on selected preventive services and therefore studies examining a variety of preventive services are necessary in order to insure that IDUs receive the comprehensive preventive care that is recommended. Finally, little is known about factors that may facilitate use of preventive services among IDUs, such as use of primary care or drug treatment services, or more frequent SEP visits, which may provide greater access to preventive services provided at the SEP. Studies to identify these factors are needed in order to best design interventions to increase use of preventive services and improve the quality of preventive care received by IDUs.
In order to address these gaps in the literature we asked the following research questions using data from a sample of clients from 23 SEPs throughout California: Do SEP clients receive recommended preventive services from any source, including SEPs and non-SEP sources? What portion of recommended services are received from SEPs versus from non-SEP sources? Are specific services more likely to be underused? Are SEP client characteristics, specifically having health insurance, use of primary care or drug treatment, or more frequent SEP visits, associated with receipt of recommended preventive services, after controlling for demographics, drug use, and risk behaviors?
Section snippets
Participants and data collection
Data for this paper came from a larger study of changes in statewide policy regarding legalization of SEPs in California (Riehman et al., 2004). A convenience sample of 560 SEP clients was recruited from 23 SEPs throughout California (approximately 25 clients per SEP) from March to September 2003. The 23 SEPs in the study represent approximately two-thirds of California SEPs in 2003, and all but one were in existence in 2000 when the larger study began. The SEPs were located in 16 different
Characteristics of sample
SEPs in the study included a variety of different organization types and ranged from very small programs with several hundred client contacts to very large programs exchanging more than 500,000 syringes per year (Table 2). The mean age of SEP clients in the sample was 43 years (standard deviation 10.7 years), 68% were male, 51% were white, 51% reported current homelessness and 56% were uninsured. The majority reported injecting heroin (76%) but use of other drugs was also common. A considerable
Discussion
Multiple studies support the effectiveness of preventive health services in preventing harmful consequences of injection drug use. Yet, effective services will not result in improved community health if IDUs in these communities do not receive needed services. We examined use of preventive services among IDUs using SEPs in California, and found that despite high need for preventive services, SEP clients failed to receive the majority of recommended preventive services, with unmet need for
Acknowledgements
The authors would like to thank the Centers for Disease Control and Prevention for funding the California Syringe Exchange Program Study (Grant #RO6/CCR918667). Support for writing this paper was also provided by the National Institute on Drug Abuse (Grant #R01DA14210), the Universitywide AIDS Research Program (Grant #IS02-DREW-705) and the Robert Wood Johnson/VA Clinical Scholars Program. The authors also thank the following project staff: Christopher Buck and Ellyn Bloomfield in Santa Monica
References (94)
- et al.
Improving entry to methadone maintenance among out-of-treatment injection drug users
J. Subst. Abuse Treat.
(2003) - et al.
Factors associated with methadone maintenance treatment retention among street-recruited injection drug users
Drug Alcohol Depend.
(2004) - et al.
Health care utilization among young adult injection drug users in Harlem, New York
J. Subst. Abuse
(2001) - et al.
Chronic illicit drug use, health services utilization and the cost of medical care
Soc. Sci. Med.
(2000) - et al.
Patient retention in mobile and fixed-site methadone maintenance treatment
Drug Alcohol Depend.
(1996) Can syringe exchange serve as a conduit to substance abuse treatment?
J. Subst. Abuse Treat.
(1998)- et al.
Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders
Drug Alcohol Depend.
(2004) - et al.
Access to medical care and service utilization among injection drug users with HIV/AIDS
Drug Alcohol Depend.
(2001) - et al.
Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance
J. Subst. Abuse Treat.
(2003) - et al.
Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection
Drug Alcohol Depend.
(2004)
A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users
Drug Alcohol Depend.
Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange
J. Subst. Abuse Treat.
A Comprehensive Approach: Preventing Blood-borne Infections Among Injection Drug Users
Adherence to hepatitis B virus vaccination at syringe exchange sites
J. Urban Health
Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco
Med. Anthropol.
Is HIV/sexually transmitted disease prevention counseling effective among vulnerable populations?: a subset analysis of data collected for a randomized, controlled trial evaluating counseling efficacy (Project RESPECT)
Sex. Transm. Dis.
Drug abuse treatment success among needle exchange participants
Public Health Rep.
Participation in an outreach-based coupon distribution program for free methadone detoxification
Hosp. Community Psychiatry
Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention
MMWR Recomm. Rep.
Update: syringe exchange programs—United States, 1998
MMWR Morb. Mortal. Wkly. Rep.
Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention
MMWR Recomm. Rep.
Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003
MMWR Morb. Mortal. Wkly. Rep.
HIV diagnoses among injection-drug users in states with HIV surveillance—25 states, 1994–2000
MMWR Morb. Mortal. Wkly. Rep.
Incidence of acute hepatitis B—United States, 1990–2002
MMWR Morb. Mortal. Wkly. Rep.
Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)
MMWR Recomm. Rep.
Satisfaction with access to health care among injection drug users, other drug users, and nonusers
J. Behav. Health Serv. Res.
Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers
Subst. Use Misuse
Primary preventive health care among injection drug users, other sustained drug users, and non-users
Subst. Use Misuse
Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–1998
Addiction
Outreach-based HIV prevention for injecting drug users: a review of published outcome data
Public Health Rep.
Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention
J. Urban Health
Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program
Am. J. Public Health
Public funding of US syringe exchange programs
J. Urban Health
Multilevel analysis in public health research
Annu. Rev. Public Health
Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services’ sexually transmitted disease clinics
J. Viral Hepat.
Manual for Primary Care Providers: Effectively Caring for Active Substance Users
Towards a Comprehensive Plan for Syringe Exchange in New York City
Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City
Addiction
On-site primary care and mental health services in outpatient drug abuse treatment units
J. Behav. Health Serv. Res.
Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
Health Serv. Res.
Linkage to medical services in the Drug Abuse Treatment Outcome Study
Med. Care
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people
Health Serv. Res.
Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users
AIDS
Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users
AIDS
Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs
J. Urban Health
Cited by (63)
Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes
2024, SSM - Qualitative Research in HealthAbolition and harm reduction in the struggle for “Care, Not Cages”
2023, International Journal of Drug PolicyTrust and service engagement among people who inject drugs after release from prison
2023, International Journal of Drug PolicyCitation Excerpt :Collectively, these post-release barriers have been referred to as the “collateral consequences of incarceration” (Treitler & Angell, 2020:2) and can negatively impact health (Semenza & Link, 2019). These experiences are exacerbated for people with a history of injecting drug use (Joudrey et al., 2019; Phillips & Lindsay, 2011) who typically have more complex unmet needs (Heinzerling et al., 2006; Treloar, Mao, & Wilson, 2016), and are at higher risk of discrimination when accessing support services and are more likely to inhabit multiple stigmatised identities (LeBel, 2012). Women exiting prison may require support with accessing employment and housing, addressing family-related needs, linkage to mental health and substance use care, and support with interpersonal functioning and acceptance (Bergseth, Jens, Bergeron-Vigesaa, & McDonald, 2011; Carlton & Segrave, 2016).
Exhausted practical sovereignty and lateral agency: Non-uptake of treatment for hepatitis C in the antiviral era
2022, International Journal of Drug PolicyCitation Excerpt :While we know that this characterisation does not describe everyone currently not taking up treatment, and that our recruitment methods no doubt shaped the range of interviews collected, this group remains important to treatment efforts and the goal of hepatitis C elimination, and therefore needs to be better understood. It is also worth considering the role of these self-same dynamics in the other health issues faced by populations affected by hepatitis C in Australia and around the world, such as injecting-related vein damage, HIV and hepatitis B coinfection, dental health issues and overdose prevention (Heinzerling, Kral, Flynn, Anderson, & Scott, 2006; Treloar et al., 2016). Viewed broadly, it is possible to argue that treatment non-uptake here tells us much about the differences, practical and political, between (as Berlant framed it) ‘epidemics’ and ‘endemics’.
Vaccination barriers and opportunities at syringe services programs in the United States, June–August 2021—A cross-sectional survey
2022, Drug and Alcohol Dependence